Aerie Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AERI Nasdaq 2834 http://www.aeriepharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aerie Pharmaceuticals Inc

Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit European Innovation Showcase - Jul 20th, 2021 8:01 pm
Aerie Pharmaceuticals Inc (AERI): Are Hedge Funds Right About This Stock? - Jul 20th, 2021 4:01 am
Aerie Pharmaceuticals Announces Appointment of Leon J. Atencia, Director of Regulatory Affairs - Jul 15th, 2021 10:30 am
Aerie Pharmaceuticals Announces Appointment of Frank Estrada, Ed.D., as Director, Salesforce Training - Jun 21st, 2021 11:00 am
Aerie Pharmaceuticals to Participate in the Raymond James Human Health Innovation Conference – UPDATED RELEASE - Jun 21st, 2021 10:45 am
Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in Japan - Jun 17th, 2021 10:30 am
Aerie Pharmaceuticals to Participate in the Raymond James Human Health Innovation Conference - Jun 15th, 2021 11:30 am
Why Is Aerie (AERI) Down 7.7% Since Last Earnings Report? - Jun 4th, 2021 3:31 pm
American Eagle, Aerie Riding Billion-Dollar Wave - May 26th, 2021 10:34 pm
Aerie's (AERI) Q1 Loss Wider Than Expected, Revenues Miss - May 6th, 2021 5:24 pm
Aerie Pharmaceuticals to Participate in the Bank of America Securities 2021 Healthcare Conference - May 6th, 2021 11:30 am
Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Misses Revenue Estimates - May 5th, 2021 10:05 pm
Aerie Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update - May 5th, 2021 8:01 pm
Aerie Pharmaceuticals, Inc. to Host Earnings Call - May 5th, 2021 7:15 pm
Is a Surprise Coming for Aerie (AERI) This Earnings Season? - May 4th, 2021 1:17 pm
CollPlant (CLGN) to Report Q1 Earnings: What's in the Cards? - May 4th, 2021 12:46 pm
Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease - Apr 29th, 2021 10:30 am
Aerie Pharmaceuticals (AERI) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Apr 28th, 2021 4:34 pm
Aerie Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host Conference Call on Wednesday, May 5, 2021 - Apr 28th, 2021 11:30 am
Aerie Pharmaceuticals Announces Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting - Apr 28th, 2021 10:30 am